ORIC Pharmaceuticals (ORIC) Revenue & Revenue Breakdown
ORIC Pharmaceuticals Revenue Highlights
00
ORIC Pharmaceuticals Revenue by Period
ORIC Pharmaceuticals Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2018-12-31 | - | - |
ORIC Pharmaceuticals Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-30 | - | 100.00% |
2024-06-30 | - | 100.00% |
2024-03-31 | - | -100.00% |
2023-12-31 | $1.54M | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2019-09-30 | - | 100.00% |
2019-06-30 | - | 100.00% |
2019-03-31 | - | - |
ORIC Pharmaceuticals Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
HOWL | Werewolf Therapeutics | $19.94M | $1.14M |
SEER | Seer | $16.66M | $4.03M |
MOLN | Molecular Partners | $7.04M | $2.74M |
ANEB | Anebulo Pharmaceuticals | - | - |
CGEM | Cullinan Oncology | - | - |
IMRX | Immuneering | - | - |
CCCC | C4 Therapeutics | - | - |
ANTX | AN2 Therapeutics | - | - |
PHVS | Pharvaris | - | - |
PMVP | PMV Pharmaceuticals | - | - |
CELC | Celcuity | - | - |
MLYS | Mineralys Therapeutics | - | - |
ORIC | ORIC Pharmaceuticals | - | - |
ELVN | Enliven Therapeutics | - | - |
EWTX | Edgewise Therapeutics | - | - |
PEPG | PepGen | - | - |